Editorial
Published on 22 Apr 2024
Editorial: Diabetes, Transplantation and Regenerative Medicine
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1388904
- 424 views
Type at least 3 characters
10 articles
Articles
Original Research
Published on 19 Apr 2024
Effect of Metformin adjunct therapy on Cardiometabolic parameters in Indian adolescents with Type 1 Diabetes: A Randomized Controlled Trial
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1353279
- 437 views
Original Research
Published on 13 Nov 2023
Impact of GAD65 and IA2 autoantibodies on islet allograft survival
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1269758
- 983 views
Original Research
Published on 31 Aug 2023
Incidence and predictors of mortality in children with diabetic ketoacidosis in the comprehensive specialized referral hospitals of West Amhara Region, Northwest Ethiopia: a retrospective follow-up study
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1204133
- 1,826 views
- 1 citation
Original Research
Published on 30 May 2023
The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1172208
- 1,853 views
Review
Published on 09 Mar 2023
Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.935872
- 5,195 views
- 4 citations
Original Research
Published on 03 Oct 2022
Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.963489
- 2,502 views
Original Research
Published on 26 Jul 2022
Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.783277
- 1,419 views
Original Research
Published on 05 Jul 2022
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.856661
- 2,314 views
- 5 citations
Original Research
Published on 12 Oct 2021
Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2021.733693
- 1,407 views